Fundraising Fox
/Companies
Sign in

Unima

DefunctYC W16

Zapopan, MX · Founded 2015 · 26 employees · 9 known investors

Find your way into Unima

Each arrow is one introduction. Sign up to fill in the first one.

11,129 people can intro you to Alejandro

Ask Ben Peters to introduce you to Alejandro Nuño Ayala

You →Ben · together at Endeavor Mexico 2016 →Alejandro

11,006 people can intro you to Rodrigo

Ask Jamie Chen to introduce you to Rodrigo Nuno

You →Jamie · together at Endeavor Mexico 2016 →Rodrigo

Sign up to find every way you can get introduced to Unima

  • Your email: who you already know at Unima, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Unima team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Unima makes portable diagnostic tests that deliver disease identification at the point of care within 15 minutes at low cost, enabling rapid detection and monitoring of infectious diseases.

BiotechHealthtechMedical DevicesHealth TechDiagnosticsMexicoLatin America

Founders & leadership· Y Combinator alumni (W16)

Unima was founded in 2015 by Rodrigo Nuno, Maria Laura Mendoza, and Alejandro Nuño Ayala.

RNRodrigo Nuno
Rodrigo NunoFounderRodrigo Nuno held operational and engineering leadership roles at Unima across veterinary product manufacturing, quality control, and IT before transitioning to head of manufacturing and Director of Engineering as the company shifted to diagnostics, where he oversaw infrastructure, architecture, and team development.
MLMaria Laura Mendoza
Maria Laura MendozaFounder
ANAlejandro Nuño Ayala
Alejandro Nuño AyalaFounderAlejandro Nuño Ayala is a biotech founder with experience developing diagnostic and therapeutic platforms. He has founded multiple biotech companies since 2006, including work on portable diagnostic technologies for infectious disease detection and antibody-based therapeutics for respiratory, ophthalmic, and autoimmune conditions, and holds expertise in product development, clinical trials, and regulatory documentation.
LM
Laura MendozaFounder

Investors · 9

Agrolimen Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

AJGreported

How we know: Y Combinator's founder network · Not right? Tell us

Avalancha VenturesreportedNew York · $300K – $2M

How we know: Y Combinator's founder network · Not right? Tell us

IDrive Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Investo CapitalreportedAalborg · $30K – $3M

How we know: Y Combinator's founder network · Not right? Tell us

SP Investment Fundreported

How we know: Y Combinator's founder network · Not right? Tell us

Thomas Jamesreported

How we know: Y Combinator's founder network · Not right? Tell us

WefunderreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 5

Cofactor GenomicsCofactor Genomics develops predictive diagnostics for cancer immunotherapy using RNA-expression models to characterize tumor microenvironments and predict patient response. The company serves oncology and precision medicine markets by enabling more accurate patient-to-therapy matching.
Signatur BiosciencesSignatur Biosciences develops molecular diagnostic solutions using qPCR technology for in vitro diagnostics, targeting clinical and laboratory markets. The company aims to deliver advanced diagnostics on widely available instrumentation to expand access to cutting-edge healthcare globally.
NumenNumen develops at-home cancer diagnostics and health data collection infrastructure using machine learning models to enable earlier intervention and improve patient outcomes.
Yemaachi BiotechnologyYemaachi creates a diverse cancer bio-database to develop oncology drugs effective across diverse patient populations. The company develops precision oncology research, diagnostics, and therapeutics with a focus on inclusion for global communities.
AminoAnalyticaAmino Analytica designs rapid molecular diagnostic tests for emerging infectious diseases and biological threats, developed in weeks rather than the traditional 12+ months. The company combines point-of-care diagnostics technology with AI-driven bionanotechnology to enable earlier detection and faster pandemic response.

Companies working in the same space as Unima.

Frequently asked questions

What does Unima do?
Unima makes portable diagnostic tests that deliver disease identification at the point of care within 15 minutes at low cost, enabling rapid detection and monitoring of infectious diseases.
Who founded Unima?
Unima was founded by Rodrigo Nuno, Maria Laura Mendoza, Alejandro Nuño Ayala in 2015.
Who are Unima's investors?
Unima's investors include Y Combinator, Agrolimen Ventures, AJG, Avalancha Ventures, IDrive Ventures, Investo Capital, SP Investment Fund, Thomas James and 1 more.
Where is Unima headquartered?
Unima is headquartered in Zapopan, MX.